Literature DB >> 17472594

Clinical importance of caffeine dependence and abuse.

Naoshi Ogawa1, Hirofumi Ueki.   

Abstract

Caffeine is the most widely consumed psychoactive substance and is a legal stimulant that is readily available to children. Caffeine has occasionally been considered a drug of abuse and the potential for dependence on caffeine has been debated. Presently, due to a paucity of clinical evidence on caffeine dependence or abuse, no such diagnosis is included in the Diagnostic and Statistical Manual of Mental Disorder-fourth edition. The authors present two cases of abuse or dependence on the caffeine contained in 'eutrophic' (energy/nutritional) beverages or caffeine preparations, followed by a review of clinical studies demonstrating evidence that some people can manifest a clinical syndrome of caffeine dependence or abuse. The cases suggest that caffeine can produce a clinical dependence syndrome similar to those produced by other psychoactive substances and has a potential for abuse. In a recent study using a structured interview and the Diagnostic and Statistical Manual of Mental Disorder-fourth edition criteria for substance dependence and abuse, a subset of the general population was found to demonstrate caffeine dependence or caffeine abuse. Therefore, the authors propose that companies or businesses manufacturing or marketing caffeine or products containing caffeine must meet the following guidelines: (i) clearly indicate the caffeine content of products containing comparatively higher quantities of caffeine; (ii) warn that such products should be avoided by infants and children wherever possible, and inform adult consumers about the precise quantity of caffeine that is considered safe for consumption; and (iii) clearly state that consuming large quantities of caffeine and the long-term use of caffeine carry health risks.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17472594     DOI: 10.1111/j.1440-1819.2007.01652.x

Source DB:  PubMed          Journal:  Psychiatry Clin Neurosci        ISSN: 1323-1316            Impact factor:   5.188


  21 in total

1.  Caffeine consumption among eating disorder patients: epidemiology, motivations, and potential of abuse.

Authors:  A Burgalassi; C E Ramacciotti; M Bianchi; E Coli; L Polese; E Bondi; G Massimetti; L Dell'osso
Journal:  Eat Weight Disord       Date:  2009-12       Impact factor: 4.652

2.  Caffeine Withdrawal and Dependence: A Convenience Survey Among Addiction Professionals.

Authors:  Alan J Budney; Pamela C Brown; Roland R Griffiths; John R Hughes; Laura M Juliano
Journal:  J Caffeine Res       Date:  2013-06

3.  Evaluating Dependence Criteria for Caffeine.

Authors:  Catherine L W Striley; Roland R Griffiths; Linda B Cottler
Journal:  J Caffeine Res       Date:  2011-12

4.  Producing low-caffeine tea through post-transcriptional silencing of caffeine synthase mRNA.

Authors:  Prashant Mohanpuria; Vinay Kumar; Paramvir Singh Ahuja; Sudesh Kumar Yadav
Journal:  Plant Mol Biol       Date:  2011-05-12       Impact factor: 4.076

5.  Effects of caffeine and its metabolite paraxanthine on intracranial self-stimulation in male rats.

Authors:  Matthew F Lazenka; F Gerard Moeller; S Stevens Negus
Journal:  Exp Clin Psychopharmacol       Date:  2015-04       Impact factor: 3.157

6.  Behavioral profile assessment in offspring of Swiss mice treated during pregnancy and lactation with caffeine.

Authors:  Roberto Laureano-Melo; Anderson Luiz Bezerra da Silveira; Fernando de Azevedo Cruz Seara; Rodrigo Rodrigues da Conceição; Cláudio da Silva-Almeida; Bruno Guimarães Marinho; Fábio Fagundes da Rocha; Luís Carlos Reis; Wellington da Silva Côrtes
Journal:  Metab Brain Dis       Date:  2016-06-04       Impact factor: 3.584

Review 7.  The Emerging Health Benefits of Coffee with an Emphasis on Type 2 Diabetes and Cardiovascular Disease.

Authors:  Siamak Bidel; Jaakko Tuomilehto
Journal:  Eur Endocrinol       Date:  2013-08-23

Review 8.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

Review 9.  Coffee and Liver Disease.

Authors:  Manav Wadhawan; Anil C Anand
Journal:  J Clin Exp Hepatol       Date:  2016-02-27

10.  Caffeine Use Disorder: A Review of the Evidence and Future Implications.

Authors:  Merideth A Addicott
Journal:  Curr Addict Rep       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.